Trial Profile
A retrospective study evaluating effect of omalizumab in severe asthmatics across ages in a real life setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2016
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 10 Nov 2016 New trial record
- 01 Oct 2016 Results published in the Respiratory Medicine